Why Is Aadi Bioscience Stock Trading Lower On Wednesday? - Aadi Bioscience ( NASDAQ:AADI )

4 weeks ago

Tuesday, Aadi Bioscience Inc. AADI announced it will halt the registration-intended PRECISION1 trial of nab-sirolimus in patients with solid tumors harboring TSC1 or TSC2 inactivating alterations.

Ticker	Sentiment	Impact
AADI	Neutral	43 %